The new tool, available as a phone app, helps identify comorbidities and produces a score to guide clinicians.
MedPage Today on MSN
Adverse Event Risks Vary Among Asthma Biologics, FDA Data Show
C HICAGO -- Adverse event risks varied across biologics used by asthma patients, an analysis of data submitted to the FDA ...
Patients with chronic rhinosinusitis with nasal polyps and uncontrolled asthma experienced greater improvements in lung ...
Roughly 6 months after starting tezepelumab for severe asthma, many patients reduced OCS dependence and meaningfully improved ...
There are steps physicians can take to prepare their patients with pulmonary issues for the changing of the seasons.
Fundamental changes in asthma management are all geared to breaking the inhalers-antibiotics-inhalers-steroids cycle ...
Patients treated for uncontrolled mild asthma had high symptom burden affecting their daily life but most had no ...
Among underserved and minority children with high-risk asthma, remote therapeutic monitoring was deemed feasible and met with ...
Each patient using inhalers with propellants in 2023 produced 140kg of CO2 emissions over a year. Read more at ...
As many as 1 in 6 (16%) patients with asthma may have comorbid diabetes, with overweight and obesity playing a role. Researchers recently examined whether glucagon-like peptide-1 receptor agonists for ...
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results